Literature DB >> 773792

Serum lysozyme levels in Crohn's disease and ulcerative colitis.

T L Peeters, G Vantrappen, K Geboes.   

Abstract

Serum lysozyme levels were determined in healthy volunteers, patients with Crohn's disease, and patients with ulcerative colitis. The mean concentration in Crohn's disease was significantly greater than in the other groups. In patients with Crohn's disease, as well as in patients with ulcerative colitis, the lysozyme levels correlated with the severity of the disease process and with the extent of the lesions: the more severe the disease and the more extensive the involvement, the higher the lysozyme levels. However, the lysozyme values of the different groups overlapped considerably. Our results indicate that lysozyme determinations have only limited discriminative value for the diagnosis of Crohn's disease and for determining the severity and the extent of the disease process in the individual patient.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 773792      PMCID: PMC1411092          DOI: 10.1136/gut.17.4.300

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Letter: Lysozyme in Crohn's disease.

Authors:  W Pruzanski; N Marcon
Journal:  N Engl J Med       Date:  1975-09-18       Impact factor: 91.245

2.  Letter: Serum lysosyme levels in Crohn's disease.

Authors:  I B Brick
Journal:  N Engl J Med       Date:  1975-05-15       Impact factor: 91.245

3.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

4.  Serum lysozyme in Crohn's disease and ulcerative colitis.

Authors:  K R Falchuk; J L Perrotto; K J Isselbacher
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

Review 5.  Plasma lysozyme--a measure of neutrophil turnover. An analytical review.

Authors:  N E Hansen
Journal:  Ser Haematol       Date:  1974

6.  Serum lysozyme in pulmonary tuberculosis.

Authors:  P E Perillie; K Khan; S C Finch
Journal:  Am J Med Sci       Date:  1973-04       Impact factor: 2.378

7.  Assay of lysozyme by its lytic action on M. lysodeikticus cells.

Authors:  G Gorin; S F Wang; L Papapavlou
Journal:  Anal Biochem       Date:  1971-01       Impact factor: 3.365

8.  Plasma muramidase: a study of methods and clinical applications.

Authors:  S Zucker; D J Hanes; W R Vogler; R Z Eanes
Journal:  J Lab Clin Med       Date:  1970-01

9.  Indices of granulocyte activity in inflammatory bowel disease.

Authors:  S P Kane; A V Hoffbrand; G Neale
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

10.  Short-term course and prognosis of Crohn's disease.

Authors:  F T De Dombal; I L Burton; S E Clamp; J C Goligher
Journal:  Gut       Date:  1974-06       Impact factor: 23.059

View more
  7 in total

1.  Serum lysozyme levels in malignant histiocytosis of the intestine.

Authors:  J R Hodges; P Isaacson; O E Eade; R Wright
Journal:  Gut       Date:  1979-10       Impact factor: 23.059

2.  Complex nature of serum lysozyme activity: evidence of thermolability in inflammatory bowel disease.

Authors:  M Ward; W D Mitchell; M Eastwood
Journal:  J Clin Pathol       Date:  1978-01       Impact factor: 3.411

3.  Serum lysozyme, serum proteins, and immunoglobulin determinations in nonspecific inflammatory bowel disease.

Authors:  O S El-Khatib; O Lebwohl; A A Attia; C A Flood; J A Stein; J G Sweeting; R T Whitlock; E F Osserman; P R Holt
Journal:  Am J Dig Dis       Date:  1978-04

4.  Muramidase (lysozyme) in Crohn's disease and in ulcerative colitis.

Authors:  W Pruzanski; N Marcon; C Ottaway; E Prokipchuk
Journal:  Am J Dig Dis       Date:  1977-11

5.  Purification and partial characterization of lysozyme from mouse small intestine.

Authors:  T L Peeters; G R Vantrappen
Journal:  Experientia       Date:  1976-09-15

6.  Factors influencing measurement of human salivary lysozyme in lysoplate and turbidimetric assays.

Authors:  J W Jenzano; S L Hogan; R L Lundblad
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

7.  Serum and faecal lysozyme in inflammatory bowel disease.

Authors:  H J Klass; G Neale
Journal:  Gut       Date:  1978-03       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.